Fig. 5From: Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trialWCST number of set-loss errors subscale score trend for each group during the trial courseBack to article page